MAGELLAN HEALTH INC's ticker is MGLN and the CUSIP is 559079207. A total of 189 filers reported holding MAGELLAN HEALTH INC in Q4 2018. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $563,000 | +62.7% | 5,923 | +62.1% | 0.00% | 0.0% |
Q3 2021 | $346,000 | -46.0% | 3,655 | -46.3% | 0.00% | -50.0% |
Q2 2021 | $641,000 | -4.2% | 6,802 | -5.2% | 0.00% | 0.0% |
Q1 2021 | $669,000 | +40.0% | 7,175 | +24.4% | 0.00% | 0.0% |
Q4 2020 | $478,000 | +89.7% | 5,766 | +73.4% | 0.00% | +100.0% |
Q3 2020 | $252,000 | -3.1% | 3,326 | -6.8% | 0.00% | 0.0% |
Q2 2020 | $260,000 | -7.5% | 3,567 | -0.6% | 0.00% | 0.0% |
Q4 2019 | $281,000 | -2.1% | 3,589 | -7.3% | 0.00% | -50.0% |
Q2 2019 | $287,000 | +0.7% | 3,870 | -10.5% | 0.00% | 0.0% |
Q1 2019 | $285,000 | +25.6% | 4,323 | +8.2% | 0.00% | 0.0% |
Q4 2018 | $227,000 | -30.4% | 3,996 | -11.6% | 0.00% | 0.0% |
Q3 2018 | $326,000 | -26.9% | 4,518 | -2.8% | 0.00% | -33.3% |
Q2 2018 | $446,000 | -7.1% | 4,650 | +3.8% | 0.00% | 0.0% |
Q1 2018 | $480,000 | -0.6% | 4,479 | -10.4% | 0.00% | 0.0% |
Q4 2017 | $483,000 | +106.4% | 5,000 | +84.6% | 0.00% | +50.0% |
Q3 2017 | $234,000 | +6.8% | 2,709 | -9.7% | 0.00% | 0.0% |
Q2 2017 | $219,000 | -17.0% | 3,000 | -21.6% | 0.00% | -33.3% |
Q1 2017 | $264,000 | -25.4% | 3,826 | -18.7% | 0.00% | -25.0% |
Q4 2016 | $354,000 | +18.8% | 4,708 | +4.0% | 0.00% | 0.0% |
Q2 2016 | $298,000 | +3.5% | 4,527 | +6.9% | 0.00% | 0.0% |
Q1 2016 | $288,000 | -10.6% | 4,234 | -19.0% | 0.00% | 0.0% |
Q4 2015 | $322,000 | +41.9% | 5,226 | +27.6% | 0.00% | +33.3% |
Q3 2015 | $227,000 | -40.4% | 4,096 | -24.6% | 0.00% | -40.0% |
Q2 2015 | $381,000 | -27.6% | 5,433 | -26.8% | 0.01% | -16.7% |
Q1 2015 | $526,000 | +10.5% | 7,425 | -6.3% | 0.01% | 0.0% |
Q4 2014 | $476,000 | -30.3% | 7,925 | -36.5% | 0.01% | -33.3% |
Q3 2014 | $683,000 | -28.9% | 12,486 | -19.1% | 0.01% | -25.0% |
Q2 2014 | $961,000 | -44.1% | 15,433 | -46.7% | 0.01% | -42.9% |
Q1 2014 | $1,719,000 | +55.1% | 28,971 | +56.8% | 0.02% | -19.2% |
Q3 2013 | $1,108,000 | +2.1% | 18,477 | -4.5% | 0.03% | +23.8% |
Q2 2013 | $1,085,000 | – | 19,340 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altalis Capital Management LLC | 130,506 | $11,262,000 | 7.39% |
Hudson Executive Capital LP | 197,400 | $17,036,000 | 4.28% |
Hood River Capital Management LLC | 507,355 | $43,785,000 | 2.78% |
Hillcrest Asset Management LLC | 102,230 | $8,822,000 | 1.60% |
Dean Capital Management | 38,719 | $3,341,000 | 1.56% |
Smith, Graham & Co., Investment Advisors, LP | 151,061 | $13,037,000 | 1.37% |
DEAN INVESTMENT ASSOCIATES, LLC | 56,950 | $4,915,000 | 0.75% |
Orbimed Advisors | 882,600 | $76,168,000 | 0.73% |
Aviance Capital Partners, LLC | 22,200 | $1,916,000 | 0.65% |
Alambic Investment Management, L.P. | 63,413 | $5,473,000 | 0.60% |